Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ADVBthis companyAdvanced Biomed Inc. Common Stock	$2.08	0.87×	0.47×	45.64×	-0.87×	78.6%	-4883.8%	-4883.8%	5231.3%	54.4%	-50.6%	-33.4%	0×	0.06×	-888.73×	9.33×	0.0%	6	-0.37	5	A+
MBIOMustang Bio, Inc.	$0.40	-2.52×	0.51×	0×	6.62×	606.6%	0.0%	0.0%	0.0%	-20.2%	-25.1%	-109.3%	0×	9.18×	0×	2.22×	0.0%	1	-35.77	2	C+
MRKRMarker Therapeutics, Inc.	$1.03	-1.89×	1.36×	0×	-0.54×	20.2%	0.0%	0.0%	0.0%	-72.4%	-76.6%	-52.7%	0×	1.29×	0×	8.39×	0.0%	2	-41.72	2	C
TNONTenon Medical, Inc.	$1.73	-0.56×	1.39×	1.78×	-0.28×	-116666.0%	59.8%	-324.3%	-318.4%	-249.1%	-166.4%	-156.8%	0.03×	0.3×	0×	2.11×	0.0%	3	-16.68	2	C
XAIRBeyond Air, Inc.	$2.26	-3.44×	18.7×	14.92×	-4.28×	513.4%	3.3%	-378.2%	-433.0%	-542.8%	-98.1%	-16.7%	3.82×	-0.54×	0×	3.8×	0.0%	3	-16.43	1	D+
Peer median	—	-2.2×	1.38×	0.89×	-0.41×	266.8%	1.6%	-162.2%	-159.2%	-160.8%	-87.4%	-81.0%	0.01×	0.8×	0×	3.01×	0.0%	3	-26.22	2	—